Mexico antitrust agency Cofece fined Moench Cooperatief and businessman Luis Doporto for failing to eliminate links between Nadro and Marzam in the pharmaceutical product distribution market.
Moench and Doporto receive fines totaling 30.9 million pesos (US$1.35 million), according to a statement from the antitrust agency.
Conditions were set by Cofece in June 2018 to close an investigation into a possible illegal concentration in the market. Moench and Doporto must still comply with measures, otherwise the antitrust agency can establish enforcement measures with a fine of up to double the current one.
Cofece started the investigation after media reports were released that were based on the Panama Papers.
Full Content: COFECE
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI